                               SEQUENCE LISTING

<110> TOBEBIO NOVEL DRUG LABORATORY CO., LTD.
 
<120> SYNERGISTIC COMBINATION OF CHEMOTHERAPY AND PEPTIDE FOR TREATING
      CANCER

<130> 36380-44715/WO (002WO)

<140> PCT/US2020/055181
<141> 2020-10-11

<150> 62/914,179
<151> 2019-10-11

<160> 12    

<170> PatentIn version 3.5

<210> 1
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
His Gly Val Ser Gly Trp Gly Gln His Gly Thr His Gly 
1               5                   10              


<210> 2
<211> 13
<212> PRT
<213> Calliphora vicina

<400> 2
His Gly Val Ser Gly His Gly Gln His Gly Val His Gly 
1               5                   10              


<210> 3
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
His Gly Gly Gly Trp Gly Gln Pro His Gly Gly Gly 
1               5                   10          


<210> 4
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
His Gly Gly Gly Gly Trp Gly Gln Gly Gly Thr His Gly 
1               5                   10              


<210> 5
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
His Gly Gly Gly Trp Gly Gln Pro His Val Gly Gly 
1               5                   10          


<210> 6
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
His Val Gly Gly Trp Gly Gln Pro His Gly Gly Gly 
1               5                   10          


<210> 7
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
His Gly Gly Gly Gly Trp Gly Gln Gly Gly Thr His Gly 
1               5                   10              


<210> 8
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
His Gly Gly Gly Gly Trp Gly Gln Gly Gly Thr His Gly 
1               5                   10              


<210> 9
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
His Gly Gly Gly Trp Gly Gln Pro His Gly Gly Gly 
1               5                   10          


<210> 10
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Gln Gly Gly Gly Gly Trp Gly Gln Pro His Gly Gly Gly Trp Gly 
1               5                   10                  15  


<210> 11
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
His Gly Gly Gly Trp Gly Gln Pro His Gly Gly Gly Trp Gly 
1               5                   10                  


<210> 12
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 12
His Gly Gly Gly Trp Gly Gln Gly Gly Gly Thr His Ser 
1               5                   10              


